Hjem › Type 1-diabetes › Pennsylvania
Type 1-diabetes kliniske forsøg i Pennsylvania
13 studier for Type 1-diabetes søger deltagere på steder i Pennsylvania.
Byer i Pennsylvania
Officiel studietekst (engelsk)
A Study of Baricitinib (LY3009104) for the Delay of Stage 3 Type 1 Diabetes in At-Risk Children and Adults
- Children's Hospital of Philadelphia (CHOP), Philadelphia
RekruttererFase 3
Alder 1 til 35 · Alle køn · Opdateret 22. sep. 2026 · NCT07222137A Study of Baricitinib (LY3009104) to Preserve Beta Cell Function in Children and Adults Newly Diagnosed With Type 1 Diabetes (BARICADE-PRESERVE)
- Children's Hospital of Philadelphia (CHOP), Philadelphia
RekruttererFase 3
Alder 1 til 35 · Alle køn · Opdateret 22. sep. 2026 · NCT07222332A Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 to 25 Years of Age With Stage 3 Type 1 Diabetes
- The Children's Hospital of Philadelphia- Site Number : 8400039, Philadelphia
RekruttererFase 3
Alder 1 til 25 · Alle køn · Opdateret 14. sep. 2026 · NCT07088068Platform Trial to Delay Stage 3 Diabetes: Comparing Teplizumab With ATG
- University of Pittsburgh, Pittsburgh
RekruttererFase 2
Alder 4 til 34 · Alle køn · Opdateret 9. sep. 2026 · NCT07216391Rezpegaldesleukin (NKTR-358) in New Onset Type 1 Diabetes Mellitus
- University of Pittsburgh, Pittsburgh
RekruttererFase 2
Alder 8 til 45 · Alle køn · Opdateret 8. sep. 2026 · NCT07142252A Randomized Phase 1/2 Trial of Low Dose Anti-thymocyte Globulin (ATG) With Subsequent Adalimumab or Verapamil in New Onset Type 1 Diabetes
- University of Pittsburgh, Pittsburgh
RekruttererFase 1/2
Alder 9 til 20 · Alle køn · Opdateret 2. sep. 2026 · NCT07061574A Safety, Tolerability, and Efficacy Study of VX-880 and VX-017 in Participants With Type 1 Diabetes
- Hospital of the University of Pennsylvania, Philadelphia
- University of Pittsburgh Medical Center Montefiore, Pittsburgh
RekruttererFase 3
Alder 18 til 65 · Alle køn · Opdateret 1. sep. 2026 · NCT04786262SAFety and Efficacy of Human Anti-thymocyte ImmunoGlobUlin SAB-142 ARresting Progression of Type 1 Diabetes
- The Children's Hospital of Philadelphia, Philadelphia
- UPMC Children's Hospital of Pittsburgh, Pittsburgh
RekruttererFase 2
Alder 5 til 40 · Alle køn · Opdateret 24. aug. 2026 · NCT07187531Effect of Inhaled Technosphere Insulin vs RAA Insulin on Exercise-Induced Hypoglycemia in Adults With T1D Using Automated Insulin Delivery
- University of Pennsylvania, Philadelphia
Rekrutterer
Alder 18 til 65 · Alle køn · Opdateret 16. jul. 2026 · NCT06880835Registry for Stage 2 Type 1 Diabetes
- Hospital of The University of Pennsylvania- Site Number : 8400021, Philadelphia
- The Children's Hospital of Philadelphia- Site Number : 8400029, Philadelphia
RekruttererObservationsstudie
Alle aldre · Alle køn · Opdateret 13. apr. 2026 · NCT06481904An Efficacy, Safety, and Tolerability Study of VX-880 in Participants With Type 1 Diabetes With a Kidney Transplant
- Perelman Center for Advanced Medicine - Endocrinology, Philadelphia
- Montefiore Clinical and Translational Research Center - Endocrinology, Pittsburgh
RekruttererFase 3
Alder 18 til 65 · Alle køn · Opdateret 23. mar. 2026 · NCT06832410Closed Loop and Education for Hypoglycemia Awareness Restoration
- University of Pennsylvania, Philadelphia
Rekrutterer
Alder 18 til 75 · Alle køn · Opdateret 3. mar. 2026 · NCT06325202TrialNet Pathway to Prevention of T1D
- Children's Hospital of Pittsburgh of UPMC, Pittsburgh
RekruttererObservationsstudieFrivillige med god helbredstilstand velkomne
Alder 2 til 45 · Alle køn · Opdateret 1. jul. 2025 · NCT00097292Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.